Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 733-0111

All results

2 results for randomized double blind vehicle controlled multicenter phase iii study evaluate

  • ALXN2050-NEPH-201

    This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study of ALXN2050 (120 and 180 milligrams [mg]) in addition to background therapy…

    Ages
    18 Years - 75 Years
    Sexes
    All
  • GCAptAIN

    This is a phase III study of efficacy and safety of secukinumab versus placebo, in combination with glucocorticoid taper regimen, in patients with giant cell…

    Ages
    50 Years - N/A
    Sexes
    All